RegMed Daily, Closing Bell, 2/27/12, stocks rise, slipped under 13,000 again, after a 100 point drop
End of Day, Cause and Effect
EOD Commentary: Stocks held gains Monday, with the Dow … flirting with and above 13,000 <for 2 hours ?> … helped by some positive economic news. On the economic front, pending home sales gained 2% to 97.0, surging to a nearly 2 year high in January; according to the National Association of Realtors <economists polled by Reuters had expected an increase of 1%>.With stocks doing so well, it’s only natural that many on Wall Street including … myself are predicting a big pullback …but so far, at least … that hasn’t happened.
Closing Bell: The NASDAQ closed UP +2.41 (+0.08%) to 2,966.16. The Dow closed DOWN -1.44 (-0.01%) to 12,981.51.
Who’s up … at the close:
- Advanced Cell Technology (OTC BB: ACTC) +$0.003 <+2.32%> to $0.11;
- Aastrom (ASTM) +$0.07 <+3.93%> to $1.85;
- Fibrocell (OTC BB: FCSC) +$0.03 <+7.14%> to $0.45;
- Geron (GERN) +$0.03 <+1.48%> to $2.05;
- ImmunoCellular (OTC BB: IMUC) +$0.06 <+3.16%> to $1.96;
- ReNeuron (RENE.L) +$0.17 <+3.55%> to $5.10;
- Tengion (TNGN) +$0.04 <+6.45%> TO $0.66;
- Verastem (VSTM) +$0.64 <+5.89%> to $11.50.
Related Posts
Categories: RegMed Daily Closing Bell
